Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isotretinoin measurement (procedure) |
Component |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin adverse reaction |
Causative agent (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to isotretinoin |
Causative agent (attribute) |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isotretinoin overdose |
Causative agent (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental isotretinoin overdose |
Causative agent (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional isotretinoin overdose |
Causative agent (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose d'isotrétinoïne d'intention indéterminée |
Causative agent (attribute) |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin [topical] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isotretinoin 500 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
embryopathie causée par l'acide rétinoïque |
Causative agent (attribute) |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing isotretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing erythromycin and isotretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Isotretinoin 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing isotretinoin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing isotretinoin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to isotretinoin |
Causative agent (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin therapy (procedure) |
Direct substance |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin 30 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin 30 mg oral capsule |
Has precise active ingredient |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin 500 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin 500 microgram/g cutaneous gel |
Has precise active ingredient |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
False |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin- and isotretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Erythromycin and isotretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Isotretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isotretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only isotretinoin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin and isotretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Embryopathy caused by isotretinoin (disorder) |
Causative agent (attribute) |
True |
Isotretinoin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |